Precision Medicine Group

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40010797

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

08/01/2026

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%

2015 (année de référence)2030

Description complète des objectifs

Near-Term Targets: Precision Medicine Group commits to reduce absolute scope 1 and 2 GHG emissions 50.0% by 2030 from a 2023 base year. Precision Medicine Group also commits to reduce absolute scope 3 GHG emissions 25.0% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

5493005RG0LYTBKL8W81

Source : Science Based Targets initiative | Données publiques